Skip to search formSkip to main contentSkip to account menu

SM 934

Known as: SM-934, SM934 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling
Dry eye disease (DED) is a multifactorial disorder of the tears and ocular surface characterized by manifestations of dryness and… 
2019
2019
A novel derivative of artemisinin inhibits cell proliferation and metastasis via down-regulation of cathepsin K in breast cancer.
2018
2018
Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages
Ulcerative colitis (UC) is a chronic, nonspecific inflammatory bowel disease (IBD) characterized by complicated and relapsing… 
2017
2017
Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases
Artemisinin, which contains a sesquiterpene trioxane skeleton, was originally isolated from Artemisia annua L., a traditional… 
2016
2016
Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells
SM934 is an artemisinin analogue with immunosuppressive properties and potent therapeutic activity against lupus-like diseases in… 
2015
2015
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy
Aim:SM934 is a novel water-soluble artemisinin derivative with immunoregulatory activities that has been used to treat murine… 
2013
2013
Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell
Background Artemisinin analogue SM934 was previously reported to possess immunosuppressive properties. The aim of this study was… 
Highly Cited
2012
Highly Cited
2012
SM934 Treated Lupus-Prone NZB×NZW F1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development
Background Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune… 
Highly Cited
2011
Highly Cited
2011
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
OBJECTIVE SM934, an artemisinin derivative, possesses potent antiproliferative and antiinflammatory properties. The aim of this… 
2009
2009
SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)